The REMAP-CAP modular protocol was a master protocol paired with domain-specific appendices and was a substantial advance in trial infrastructure. Prof. Steve Webb explains how this structure replaced the inefficiency of static, all-in-one protocols. With modularity, adding a new domain and operationalizing it, including data management, could be achieved in three or four weeks. This design proved its worth during the COVID-19 pandemic, supporting efficient adaptation and robust evidence generation under real-world crisis constraints. Learn more about the origins of REMAP-CAP on the latest episode of "In the Interim..." berryconsultants.com/resourc…

REMAP-CAP's @DerdeLennie adds her voice to a beautiful celebration of #InternationalDayofWomenandGirlsinScience 👇

REMAP-CAP expanded immensely during the #COVID19 #pandemic, but in many regions it predates that period. 🇯🇵 @RemapCap Japan commenced in 2020 & has had an outsized impact on #clinicalresearch in the country, paving the way for other adaptive platform trials. #10YearsREMAPCAP

🫁 Today we mark #WorldPneumoniaDay2024. The #remapcapfamily has been tackling community-acquired #pneumonia for a decade now, and our joint efforts have positively impacted many lives around the world. #10YearsREMAPCAP #infectiousdiseases #clinicalresearch #covid19

Keeping patients, their families and the public engaged is a strength of REMAP-CAP. 🇵🇰 The Pakistani Patient & Public Involvement & Engagement group's 2024 summit gained national news coverage and presented networking opportunities. 👉 youtube.com/watch?v=3Lsgedtz… #10YearsREMAPCAP

Empowering Patients - Revising Informed Consent Processes for Critical Care Trials in Pakistan Our public group has worked with us to make informed consent for @MegaROXtrial and @remap_cap more culturally sensitive and relevant in the Pakistani context

What does being a pragmatic trial mean in South Asia? We evaluated 3 international trials (@remap_cap @MegaROXtrial RECOVERY) Absent post-discharge follow up and poor physician and public understanding of trials constrained their incorporation into usual care

Our friends at the Dutch hospital @UMCU_Intl highlight REMAP-CAP's exceptional contribution to tackling community-acquired #pneumonia & #COVID19 🫁 Read the article 👉 research.umcutrecht.nl/stori… #10YearsREMAPCAP @Lennie333 @MarcBonten @IenI_UMCUtrecht

REMAP-CAP team members attended the Federated Platform Trials meeting in Dublin organised by @ICCCTN, @ISARIC1 & @AcuteCareTrials. The focus was on principles to enable platform #clinicaltrials to federate effectively, particularly in the field of #criticalcare.

Thank you to our fantastic ICU team on #Red4Research day for their ongoing support with Clinical Trials @Airways_3 @AbbruptTrial @GenomiccStudy @iRehabTrial @remap_cap ❤️

🇵🇰 @Zuedu is one of 7 sites in Pakistan currently participating in REMAP-CAP. Its Patient and Public Involvement & Engagement group recently produced a great video explaining #clinicaltrials in Urdu and with locally relevant graphics. Check it out 👉 youtube.com/watch?v=dCZqm6hW…

🚩 Major REMAP-CAP milestone: 14.000 patients have been enrolled in the trial globally. A big THANK YOU to the whole #remapcapfamily for the dedication and commitment to improving outcomes for patients with community-acquired #pneumonia 👏🏻👏🏾👏🏼 #10YearsREMAPCAP

Attending the #ERSCongress2024? Join this postgrad course to hear @Lennie333 discuss the landscape of adaptive platform #clinicaltrials in #criticalcare and the REMAP-CAP trial 👇 @EuroRespSoc @UMCU_Intl @IenI_UMCUtrecht @EU_Commission

There was a lot of discussion around the presentation of the @remap_cap steroids for non-COVID community-acquired pneumonia domain results at #CCR24 Steve Webb from @anzicsctg & Scott Berry from @BerryConsultant discuss their findings The data are presently unpublished

Those working on the REMAP-CAP trial in Europe are eligible for an attendance grant from @Ecraid. Follow the link below for details on how to apply 👇

Professor Anthony Gordon, REMAP-CAP's UK Chief Investigator, has been awarded an MBE (Member of the Order of the British Empire) for his contribution to #criticalcare. Congratulations on this important recognition, @agordonICU 👏 imperial.nhs.uk/about-us/new… @imperialcollege

🏁 @CritCareReviews Meeting 2024 begins tomorrow! 🚩 Among the 11 major trial results to be presented at #CCR24 are REMAP-CAP findings. Don't miss our exciting presentations. ▶️ Not attending? Watch the free livestream at criticalcarereviews.com/meet…

REMAP-CAP was highlighted by @ThwaitesGuy as "a trial that really matters". Watch his #ESCMIDGlobal presentation online 👇

#CCR24 kicks off in 7 days! Don't miss the REMAP-CAP presentations: 💊 Statins Trial Review 💊 Ivermectin Trial Results 💊 Steroids Trial Results Check out the full programme 👉 criticalcarereviews.com/meet… Support @CritCareReviews 👉 criticalcarereviews.com/home…

how did it go? impressive summary of @remap_cap findings #PratoAnaes2024 @stephen_t_webb @pinkney_t @KBibbinsDomingo @jocalynclark @HughHemmings @TWSnelling @HeliScottpterDr @yeung_joyce remapcap.org/publications